Partner Brent Babcock was quoted in, “Pharma, Biotech Patent Holders Lament Appeal Board Survival,” an article published by Bloomberg Law.
Excerpt: “Pharmaceutical and life sciences patent holders may be unhappy the Supreme Court this week didn’t spike a review board known for invalidating patents at a high rate, but must be relieved the board can no longer do so piecemeal.”
Read full article here >> (Subscription Required)